A9535 | Establishes a generic drug research and development laboratory and production facility and the empire state biosimilar insulin initiative | Smith & Moses
A9535Assembly
Official Title
Establishes a generic drug research and development laboratory and production facility and the empire state biosimilar insulin initiative
2023-2024 SessionPhil SteckAffects: Public Health Law
Status
In Assembly Committee
Health
Impact Rating
Unable to calculate
Passage Likelihood
Unable to calculate
Bill Progress
✓
Introduced
👥
In Committee
✅
Committee Passed
📋
Floor Calendar
🏛️
Passed Chamber
🔄
Other Chamber
✓
Introduced
👥
In Committee
✅
Committee Passed
📋
Floor Calendar
🏛️
Passed Chamber
🔄
Other Chamber
What's Happening
Why It Matters
Waiting for summary...
Get alerts when A9535 moves
Create a free account to track this bill and get emailed when its status changes — committee votes, floor action, signing, or veto.